Health Care › Wholesale-Drugs, Proprietaries & Druggists' Sundries
MEDS Stock Price Correlated With TRxADE HEALTH Financials
External Links ⌄
Income Statement
Cash Flow
Balance Sheet
MEDS Income Statement
Enable JavaScript and reload
Revenue, Net:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
MEDS Cash Flow
Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:
MEDS Balance Sheet
Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:
COMPANY PROFILE
NOTE
1 – ORGANIZATION AND BASIS OF PRESENTATION
TRxADE
HEALTH, INC. (“ we ”, “ our ”, “ Trxade ”, and the “ Company ”) owns
100 %
of Trxade, Inc., Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC, Alliance Pharma Solutions, LLC, and Bonum Health,
LLC. The merger of Trxade, Inc. and Trxade Group, Inc. occurred in May 2013. Community Specialty Pharmacy was acquired in October 2018.
SOSRx was created in February 2022 between Exchange Health and Trxade Health. From January 2021 to December 2021 (from when it
was dissolved) the Company also owned 100 %
of MedChecks, LLC.
Trxade,
Inc., operates a web-based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories
and services.
Integra
Pharma Solutions, LLC (d.b.a. Trxade Prime), is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products to
customers. Trxade Prime customers include all healthcare markets including government organizations, hospitals, clinics and independent
pharmacies nationwide.
Alliance
Pharma Solutions, LLC (d.b.a. DelivMeds) invested in SyncHealth MSO, LLC, a managed services organization, in January 2019, which investment
was divested in February 2020. DelivMeds is currently being rebranded and the consumer-based app is still being developed. To date we
have not generated any revenue from this product.
Community
Specialty Pharmacy, LLC, is an accredited independent retail pharmacy with a focus on a community-based model offering home delivery
services to patients.
Bonum
Health, LLC, was formed to hold certain telehealth assets acquired in October 2019. The “ Bonum Health Hub ” was launched
in February 2020; however, due to the COVID-19 pandemic the Company does not anticipate installations moving forward, and has taken a
write off of the hubs purchased at June 30, 2021, in Loss on Inventory Investments of $ 143,891. The Bonum Health mobile application is
available on a subscription basis, primarily as a stand-alone telehealth software application that can be licensed on a business-to-business
(B2B) model to clients as an employment health benefit for the clients’ employees.
On
February 15, 2022 the Company entered into a relationship with Exchange Health, LLC, a technology company providing an online platform
for manufacturers and suppliers to sell and purchase pharmaceuticals (“Exchange Health”). SOSRx LLC, the created entity
relating to the relationship, a Delaware limited liability company, was formed in February 2022, and is owned 51 %
by the Company and 49 %
by Exchange Health.
Basis
of Presentation - The accompanying unaudited interim consolidated financial statements of TRxADE HEALTH, Inc. have been prepared
in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange
Commission and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s
Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the Securities and Exchange Commission on March 28, 2022.
In
the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial
position and the results of operations for the interim periods presented have been reflected herein. The results of operations for the
interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that
would substantially duplicate the disclosures contained in the audited financial statements for the year ended December 31, 2021, as
reported in the Company’s Annual Report on Form 10-K have been omitted.
Accounts
Receivable – The Company’s receivables are from customers and are typically collected within 90 days. The Company determines
the allowance based on known troubled accounts, historical experience, and other currently available evidence. During the
1 – ORGANIZATION AND BASIS OF PRESENTATION
TRxADE
HEALTH, INC. (“ we ”, “ our ”, “ Trxade ”, and the “ Company ”) owns
100 %
of Trxade, Inc., Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC, Alliance Pharma Solutions, LLC, and Bonum Health,
LLC. The merger of Trxade, Inc. and Trxade Group, Inc. occurred in May 2013. Community Specialty Pharmacy was acquired in October 2018.
SOSRx was created in February 2022 between Exchange Health and Trxade Health. From January 2021 to December 2021 (from when it
was dissolved) the Company also owned 100 %
of MedChecks, LLC.
Trxade,
Inc., operates a web-based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories
and services.
Integra
Pharma Solutions, LLC (d.b.a. Trxade Prime), is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products to
customers. Trxade Prime customers include all healthcare markets including government organizations, hospitals, clinics and independent
pharmacies nationwide.
Alliance
Pharma Solutions, LLC (d.b.a. DelivMeds) invested in SyncHealth MSO, LLC, a managed services organization, in January 2019, which investment
was divested in February 2020. DelivMeds is currently being rebranded and the consumer-based app is still being developed. To date we
have not generated any revenue from this product.
Community
Specialty Pharmacy, LLC, is an accredited independent retail pharmacy with a focus on a community-based model offering home delivery
services to patients.
Bonum
Health, LLC, was formed to hold certain telehealth assets acquired in October 2019. The “ Bonum Health Hub ” was launched
in February 2020; however, due to the COVID-19 pandemic the Company does not anticipate installations moving forward, and has taken a
write off of the hubs purchased at June 30, 2021, in Loss on Inventory Investments of $ 143,891. The Bonum Health mobile application is
available on a subscription basis, primarily as a stand-alone telehealth software application that can be licensed on a business-to-business
(B2B) model to clients as an employment health benefit for the clients’ employees.
On
February 15, 2022 the Company entered into a relationship with Exchange Health, LLC, a technology company providing an online platform
for manufacturers and suppliers to sell and purchase pharmaceuticals (“Exchange Health”). SOSRx LLC, the created entity
relating to the relationship, a Delaware limited liability company, was formed in February 2022, and is owned 51 %
by the Company and 49 %
by Exchange Health.
Basis
of Presentation - The accompanying unaudited interim consolidated financial statements of TRxADE HEALTH, Inc. have been prepared
in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange
Commission and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s
Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the Securities and Exchange Commission on March 28, 2022.
In
the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial
position and the results of operations for the interim periods presented have been reflected herein. The results of operations for the
interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that
would substantially duplicate the disclosures contained in the audited financial statements for the year ended December 31, 2021, as
reported in the Company’s Annual Report on Form 10-K have been omitted.
Accounts
Receivable – The Company’s receivables are from customers and are typically collected within 90 days. The Company determines
the allowance based on known troubled accounts, historical experience, and other currently available evidence. During the
Free historical financial statements for TRxADE HEALTH Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 39 quarters since 2015. Compare with MEDS stock chart to see long term trends.
Data imported from TRxADE HEALTH Inc. SEC filings. Check original filings before making any investment decision.